Zobrazeno 1 - 10 of 79 pro vyhledávání: '"D Easty"'
1
Class II MHC antigen (HLA-DR) expression in the developing sweat gland
Autor: I. A. Lampert, D. Easty, D. J. Evans
Publikováno v: Tissue Antigens. 28:269-274
Class II MHC antigen (HLA-DR) is a normal constituent of the ductular lining cells of the sweat gland. In development, HLA-DR is first expressed on the developing bud of the growing gland as it extends down from the epidermis. The cells immediately b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5baf3edd219db73123641719bb53c88
https://doi.org/10.1111/j.1399-0039.1986.tb00495.x
Zobrazit plný text záznamu
3
Changes in protein expression during melanoma differentiation determined by computer analysis of 2-D gels
Autor: K Patel, Magdi H. Yacoub, Michael J. Dunn, Angelika Görg, Albert Domscheit, Wilhelm Postel, Colin Seymour, Siegfried Günther, D Easty, I R Hart
Publikováno v: Clinical & Experimental Metastasis. 9:221-230
Cytodifferentiation in many melanocytic cells is regulated through the adenylate cyclase-cAMP pathway. To analyse the molecular changes associated with this process we have compared the proteins produced by two closely related cell lines which, thoug
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a248de889d0ade1cc92555205b4db567
https://doi.org/10.1007/bf01753726
Zobrazit plný text záznamu
5
High Expression of Macrophage Stimulating Protein (MSP) Correlates with Survival Benefit in Malignant Pleural Mesothelioma
Autor: Steven G. Gray, D. Easty, Alex Soltermann, Daisuke Nonaka, Isabelle Opitz, Dean A. Fennell, Anne-Marie Baird, Luciano Mutti, Kenneth J. O'Byrne, Harvey I. Pass
Publikováno v: Annals of Oncology. 23:ix495
Introduction RON/MST1R is a member of the MET tyrosine kinase family and has a putative role in several cancers. Macrophage stimulating protein (MSP) is the only known ligand for RON/MST1R. The MSP-RON signalling pathway has been implicated in a vari
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::759691ab27e65791572851d9dbf2e60c
https://doi.org/10.1016/s0923-7534(20)34077-1
Zobrazit plný text záznamu
6
Phase II Study of Amrubicin in Patients with Refractory or Resistant Relapsed Small-Cell Lung Cancer: Japan Clinical Oncology Group Study (JCOG0901)
Autor: Masaharu Nishimura, G. Galffy, Q. Cheng, N. Stjepanovic, B. B. Oven Ustaalioglu, M.A. Damiano, G. Sajjady, J. Cai, B. Wallin, J. Dimitroulis, M. Reck, Judit Kocsis, B. Dome, S. Mellor, Y. Okuma, G. Le Teuff, N. Muzzafar, S. Yang, T. Tamura, S.A. Kazmi, G. Fust, H. Isobe, L. Graf, R. Eckert, D. Easty, S. Ahn, M. Chacon, D.A. Fennell, H. Daga, D. Pérez-Callejo, Raffaele Califano, Y. Ohe, Angela C. Casbard, Pablo Martinez, Y. Hosomi, H. Murakami, M. Salcedo, Y-C. Kim, Mustafa Canhoroz, Y. Fujita, A. Verlicchi, I. Oh, M.A. Burgio, S. Imtiaz, C. Kurkjian, M.A. Montero, A. Rosales, D. Pérez Callejo, C. Park, P. Ibeas, Susana Cedres, S. Heavey, Thierry Jahan, X. Wang, K. Kim, G. Stathopoulos, W. Sterlacci, M. Palka, N.B. Leighl, Satoshi Oizumi, Benjamin Besse, E. Almagro Casado, G. Gavelli, M. Yomoda, K. Takamura, C. Maximiano, J.W. Heyburn, Selcuk Seber, C. Lou, Wolfgang Hilbe, L. Tamasi, W. Mao, L. Ampollini, A. Santo, Jason F. Lester, D. Simos, H. Yang, J-C. Soria, H. Jamnig, S. Kuom, H. Ban, S. Sanna, Gareth Griffiths, Y. Ichinose, K. Na, D. Tsavdaridis, Taner Korkmaz, Z. Segota, R. Buosi, Lisette Sheena Nixon, G. Pall, K.A. Gately, M. Leschke, C. Martin, T. Schmid, P. Godwin, Hirotoshi Dosaka-Akita, M.E. Guiterrez, L. Lei, J. Edwards, C. Ho, Z. Prohaszka, David Planchard, H. Lu, Athanassios Argiris, J. Qin, M. Nevinny, Yvonne Summers, Y. Takagi, M. Endo, K.J. O'Byrne, T. Okamura, Z. Orosz, B. Cantos, A. Martinez, A. Falco, M. Mezzetti, E. Flechter, H. Watanabe, Umut Kefeli, G. Zangerl, M.S. Liew, R. Hassan, Serdar Turhal, A.C. Mita, I.A. Muazzam, Z. Bartfai, D. Nonaka, O.S. Breathnach, M. Monti, Harvey I. Pass, C. Poleri, O. Balvan, S. White, L. Mutti, J. Margery, W. Kim, Hedy L. Kindler, Hajime Asahina, M. Rosenberg, Mahmut Gumus, A. Pircher, A. López-González, N. Siddiqui, D. Torrejon Castro, V. Vilchez, R. Chacon, Dean A. Fennell, K. Umezawa, A. Szilagyi, T. Kojima, R. Mastico, Enriqueta Felip, Y. Zhang, P. Wheatley-Price, R. Guild, Rastilav Bahleda, D. Traphalis, M. Sergi, O. Ben Itzhak, T. Shibata, A.K. Patané, K. Das, S. Kumar, O. Vaisman, J. Stathopoulos, N. Yasar, W.M. Grogan, A. Soltermann, Steven G. Gray, H. Kang, J. Clince, M. Faehling, C.L. Hann, M. Barr, Lyudmila Bazhenova, B.G. Doger de Speville, A. Ruiz-Valdepeñas, Anne-Marie Baird, C. Kosmas, Y. Nakahara, T. Harada, J.D. Maltzman, M. Provencio Pulla, J. Parno, N. Yamamoto, M. Wollner, Antoine Hollebecque, David R. Spigel, Willi Oberaigner, Y. Kawai, M. Shibuya, E. Sari, E. Almagro-Casado, M. Mendez Garcia, N.J. Coleman, J. Raphael, Johanna C. Bendell, M. Fiegl, I. Opitz, G. Diaz, E. Jennions, Christophe Massard, G. Genestreti, M. Iguchi, P. Fatato
Publikováno v: Annals of Oncology. 23:ix492
Background Standard therapy for refractory or resistant relapsed small-cell lung cancer (SCLC) has not yet been established. We conducted an open-label, multicenter, non-randomized phase II study to confirm the efficacy and safety of amrubicin, a top
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3285e282bfecba0a422afa8f2b2c30d7
https://doi.org/10.1093/annonc/mds415
Zobrazit plný text záznamu
7
Cataract extraction: patient characteristics and preferences
Autor: K, Lowe, D, Gregory, R, Jeffery, D, Easty
Publikováno v: Health trends. 24(4)
This paper reports the results of a comparative study of inpatient and day case patients undergoing a cataract extraction with intraocular lens implant. An assessment was made of their home circumstances, and included questions about their health and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b5a58e4fd357cd88532061a84ff40fce
https://pubmed.ncbi.nlm.nih.gov/10171370
Zobrazit plný text záznamu
8
Tumor cell progression and differentiation in metastasis
Autor: I R, Hart, D, Easty
Publikováno v: Seminars in cancer biology. 2(2)
The development and evolution of tumors is regulated by both genetic and epigenetic events. It is thought that these processes tend to drive neoplastic development in opposing directions so that tumor progression, predominantly as a consequence of mu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ac22de3363fef4cbd0d15eb19539c87d
https://pubmed.ncbi.nlm.nih.gov/1912522
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje